<?xml version="1.0" encoding="UTF-8"?>
<p>Even in wealthy countries such as the United States, many COVID-19 patients have struggled with the cost of treatment, especially those who have suffered from severe COVID-19 and its subsequent complications [
 <xref rid="R1" ref-type="bibr">1</xref>]. COVID-19 patients are likely to face even more challenges accessing and affording medical treatment in developing countries, especially low-income countries with under-resourced healthcare systems. Furthermore, many individuals in low-income countries may be at high-risk of suffering severe COVID-19 because of weak lungs or compromised immune systems from chronic malnutrition, tuberculosis, or HIV.
</p>
